Aperture Science is a clinically embedded healthcare company operating across medical devices and trusted healthcare data infrastructure. Built from within regulated healthcare environments, we apply a compliance-first, clinically grounded approach to improving patient care, medical technology, and healthcare innovation. Our work is shaped by real-world clinical operations, ensuring quality, accountability, and long-term system integrity. In medical devices, Aperture Science maintains an active presence in renal care therapies and holds exclusive South African distribution rights for Sinomed cardiovascular stents and balloons, strengthening our clinical footprint and hospital partnerships. Alongside this, Aperture Science supports the responsible advancement of healthcare AI and digital health through clinically validated healthcare data infrastructure. Our focus on clinical accuracy, governance, and regulatory awareness positions us as a high-trust partner for organizations operating in complex, high-stakes healthcare environments. Aperture Science is not a generic healthcare vendor. Our capabilities are built through sustained clinical engagement and disciplined execution, creating defensibility through trust rather than scale alone. Follow Aperture Science for updates as we continue to build durable healthcare infrastructure with real-world impact.
| Employees | 17 (17 on RocketReach) |
| Founded | 2020 |
| Industry | Hospitals and Health Care |
Looking for a particular Aperture Science employee's phone or email?
Paprika Papurika is the CEO of Aperture Science.
17 people are employed at Aperture Science.